Edgewise Therapeutics, Inc. EWTX Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Edgewise Therapeutics, Inc.’s reported figures.
The official record: Edgewise Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Edgewise Therapeutics, Inc.'s invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Edgewise Therapeutics, Inc.'s invested capital?
- Edgewise Therapeutics, Inc. (EWTX) reported invested capital of $463.79M in Q1 2026.
- How has Edgewise Therapeutics, Inc.'s invested capital changed year-over-year?
- Edgewise Therapeutics, Inc.'s invested capital increased by 20.7% year-over-year, from $384.36M to $463.79M.
- What is the long-term trend for Edgewise Therapeutics, Inc.'s invested capital?
- Over 3 years (2022 to 2025), Edgewise Therapeutics, Inc.'s invested capital has grown at a 12.2% compound annual growth rate (CAGR), from $329.13M to $465.1M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).